DNAPrint Genomics (DNAG) Osake Kurssi

DNAPrint Genomics Inc is primarily active in the field of genetic research and biotechnology.

The main competitors of DNAPrint Genomics Inc in the market are companies like Illumina Inc, Thermo Fisher Scientific Inc, and QIAGEN NV.

DNAPrint Genomics Inc, founded in [year], is a leading biotechnology company specializing in genetic research and related services. With a strong focus on genomics, DNAPrint Genomics Inc has made significant contributions to the field of DNA analysis. The company has developed innovative technologies that enable precise identification and profiling of individual genetic traits, leading to breakthroughs in personalized medicine and forensic investigations. Over the years, DNAPrint Genomics Inc has established itself as a trusted partner for academic institutions, pharmaceutical companies, and law enforcement agencies seeking cutting-edge genomic solutions. With its commitment to scientific excellence and continuous innovation, DNAPrint Genomics Inc continues to drive advancements in the field of genetic research.

DNAPrint Genomics Inc, a pioneering company in the field of genomics, has achieved several significant milestones. One notable achievement is the successful development of cutting-edge DNA analysis technologies. Through their innovative approach, DNAPrint Genomics Inc has revolutionized genetic research, enabling deep insights into human ancestry and personalized medicine. Additionally, the company has established strategic partnerships with leading pharmaceutical companies, facilitating the advancement of precision medicine. DNAPrint Genomics Inc's commitment to excellence and continuous innovation has positioned them as a front-runner in the genomics industry. As a result, they have garnered substantial recognition and acclaim for their groundbreaking contributions to genetic science.

DNAPrint Genomics Inc is primarily present in the United States.

DNAPrint Genomics Inc is committed to pioneering advancements in genomics research. The company values innovation, scientific excellence, and ethical practices. With a focus on DNA analysis and genetic testing, DNAPrint Genomics Inc aims to provide valuable insights for personalized medicine, ancestry tracing, and forensic applications. By integrating cutting-edge technologies and a customer-centric approach, the company strives to deliver accurate and reliable genomic information. DNAPrint Genomics Inc continually seeks collaborations and partnerships to further expand its impact in the genomics industry.

Nykyisellä valuuttakurssilla DNAPrint Genomics-osake noteerataan hintaan 0,00 EUR (0,00 USD).

DNAPrint Genomics Inc. is a US company specializing in the development of DNA-based diagnostic and forensic solutions. It was founded in 2000 and is headquartered in Sarasota, Florida. The company's products and services are primarily offered in the US, Europe, and Asia. DNAPrint Genomics focuses on developing DNA tests for clinical diagnostics, forensics, and pharmaceutical research. However, the company specializes in the application of DNA tests in forensic science. They offer a variety of services and products to meet the needs of investigators and law enforcement agencies in identifying perpetrators and victims. The company's products include various forensic tests, such as the CE-HEISEN DNA test system. These tests are specifically designed for determining DNA profiles and can help solve crimes. They also offer tests that can help determine family relationships, such as the family verification program. DNAPrint Genomics also has a clinical diagnostics division. This division offers a wide range of DNA tests that can be used for disease diagnosis and treatment. One of their most well-known product lines is DNA gene analysis, which is used to determine disease risks and personalized medicine. Another division of the company is pharmaceutical research. Here, customers can use DNA diagnostics to develop drugs and conduct clinical trials. The company also offers gene therapy tools to enhance the effectiveness of medications. DNAPrint Genomics also manufactures customized DNA tests tailored to the specific needs of customers. This allows customers to use DNA analysis to optimize their business processes and increase efficiency. To provide their products and services, DNAPrint Genomics works closely with customers in research, clinical diagnostics, and forensic science. The company also has a strong partnership with the government and law enforcement agencies to assist in solving crimes. Overall, DNAPrint Genomics has established itself as one of the leading DNA analysis companies in forensics, clinical diagnostics, and pharmaceutical research. Their products and services are tailored to the needs of their customers and can contribute to gaining crucial insights and improving the quality of life for people worldwide.

Liikevaihtoa ei voida laskea DNAPrint Genomics:lle tällä hetkellä.

Voittoa ei voida laskea DNAPrint Genomics:lle tällä hetkellä.

P/E-suhdetta ei voida laskea DNAPrint Genomics:lle tällä hetkellä.

P/S-suhdetta ei voida laskea DNAPrint Genomics:lle tällä hetkellä.

DNAPrint Genomics:n Eulpool-laatuscore on 2/10.

DNAPrint Genomics:n ISIN on US23324Q2021. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

DNAPrint Genomics:n WKN on A0ETWM. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

DNAPrint Genomics:n ticker on DNAG. Tämä pörssinoteeraus käytetään DNAPrint Genomics-osakkeiden kauppaan pörssissä.